Quantifying proteins by mass spectrometry: The selectivity of SRM is only part of the problem

Precise and accurate protein quantification is critical to many areas of proteomics. Antibody‐based approaches are costly and time‐consuming to develop, consequently, there is considerable interest in alternative quantitative methods that are versatile and can be implemented without the considerable delays associated with antibody development and characterization. Approaches based on MS have therefore attracted considerable attention and are now frequently touted as the most practical and powerful of all options. Nevertheless, there are serious limitations associated with quantifying a protein based on tandem mass analysis of one or two peptides generated by either chemical or enzymatic cleavage. In an accompanying Viewpoint article, Molloy and coworkers point out that selectivity is not necessarily guaranteed despite the power of SRM. Here we address an additional concern that can also compromise specificity. In complex mammalian systems, multiple proteins can serve as precursors of a single peptide and consequently, depending on the peptide(s) selected, protein levels may be significantly under‐ or overestimated.

[1]  Mark P. Molloy,et al.  How specific is my SRM?: The issue of precursor and product ion redundancy , 2009, Proteomics.

[2]  S. Mundlos,et al.  Cobblestone-like brain dysgenesis and altered glycosylation in congenital cutis laxa, Debré type , 2008, Neurology.

[3]  S. O’Rahilly,et al.  Mutations in the amino-terminal region of proopiomelanocortin (POMC) in patients with early-onset obesity impair POMC sorting to the regulated secretory pathway. , 2008, The Journal of clinical endocrinology and metabolism.

[4]  Xinping Fang,et al.  LC-MS/MS approach for quantification of therapeutic proteins in plasma using a protein internal standard and 2D-solid-phase extraction cleanup. , 2007, Analytical chemistry.

[5]  M. Maurel,et al.  Evaluation of a peptide ELISA for the detection of rituximab in serum. , 2007, Journal of immunological methods.

[6]  N. Packer,et al.  Glycosylation of sputum mucins is altered in cystic fibrosis patients. , 2007, Glycobiology.

[7]  F. Ceciliani,et al.  The acute phase protein alpha1-acid glycoprotein: a model for altered glycosylation during diseases. , 2007, Current protein & peptide science.

[8]  S. Raghav,et al.  Altered expression and glycosylation of plasma proteins in rheumatoid arthritis , 2006, Glycoconjugate Journal.

[9]  J. D. del Río,et al.  Reelin expression and glycosylation patterns are altered in Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Patterson Data analysis—the Achilles heel of proteomics , 2003, Nature Biotechnology.

[11]  Y. Azuma,et al.  Altered glycosylation of α1-acid glycoprotein in patients with inflammation and diabetes mellitus , 2003 .

[12]  J. Rhodes,et al.  Altered glycosylation in inflammatory bowel disease: A possible role in cancer development , 2001, Glycoconjugate Journal.

[13]  P. Cohen,et al.  The regulation of protein function by multisite phosphorylation--a 25 year update. , 2000, Trends in biochemical sciences.

[14]  R. Davis,et al.  Regulation of transcription factor function by phosphorylation , 2000, Cellular and Molecular Life Sciences CMLS.

[15]  T. Orntoft,et al.  Clinical aspects of altered glycosylation of glycoproteins in cancer , 1999, Electrophoresis.

[16]  E. Zenteno,et al.  Altered Glycosylation Pattern of Proteins in Alzheimer Disease , 1998, Journal of neuropathology and experimental neurology.

[17]  L. Scalfi,et al.  Altered glycosylation of pituitary gonadotropins in anorexia nervosa: an alternative explanation for amenorrhea. , 1995, European journal of endocrinology.

[18]  M. Kwatra,et al.  Regulation of Receptor Function by Protein Phosphorylation , 1990, Annals of the New York Academy of Sciences.

[19]  P. Greengard,et al.  Protein Phosphorylation and Neuronal Function , 1985, Journal of neurochemistry.

[20]  M. D. De Buyzere,et al.  Altered glycosylation of gamma-glutamyltranspeptidase (GGT) in seminal fluid from men with accessory gland infection. , 1985, International journal of andrology.

[21]  Zhongqi Zhang,et al.  Mass spectrometry for structural characterization of therapeutic antibodies. , 2009, Mass spectrometry reviews.

[22]  R. Dwek,et al.  Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. , 2008, Anti-cancer agents in medicinal chemistry.

[23]  M. Calero,et al.  Altered glycosylation of acetylcholinesterase in the Creutzfeldt-Jakob cerebrospinal fluid , 2007, Journal of Molecular Neuroscience.

[24]  Y. Azuma,et al.  Altered glycosylation of alpha1-acid glycoprotein in patients with inflammation and diabetes mellitus. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[25]  L. Johnson,et al.  The effects of phosphorylation on the structure and function of proteins. , 1993, Annual review of biophysics and biomolecular structure.